Human ATG4 autophagy proteases counteract attachment of ubiquitin-like LC3/GABARAP proteins to other cellular proteins.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
23 08 2019
Historique:
received: 27 06 2019
pubmed: 19 7 2019
medline: 27 3 2020
entrez: 19 7 2019
Statut: ppublish

Résumé

Microtubule-associated protein 1 light chain 3 α (LC3)/GABA type A receptor-associated protein (GABARAP) comprises a family of ubiquitin-like proteins involved in (macro)autophagy, an important intracellular degradation pathway that delivers cytoplasmic material to lysosomes via double-membrane vesicles called autophagosomes. The only currently known cellular molecules covalently modified by LC3/GABARAP are membrane phospholipids such as phosphatidylethanolamine in the autophagosome membrane. Autophagy-related 4 cysteine peptidase (ATG4) proteases process inactive pro-LC3/GABARAP before lipidation, and the same proteases can also deconjugate LC3/GABARAP from lipids. To determine whether LC3/GABARAP has other molecular targets, here we generated a pre-processed LC3B mutant (Q116P) that is resistant to ATG4-mediated deconjugation. Upon expression in human cells and when assessed by immunoblotting under reducing and denaturing conditions, deconjugation-resistant LC3B accumulated in multiple forms and at much higher molecular weights than free LC3B. We observed a similar accumulation when pre-processed versions of all mammalian LC3/GABARAP isoforms were expressed in ATG4-deficient cell lines, suggesting that LC3/GABARAP can attach also to other larger molecules. We identified ATG3, the E2-like enzyme involved in LC3/GABARAP lipidation, as one target of conjugation with multiple copies of LC3/GABARAP. We show that LC3B-ATG3 conjugates are distinct from the LC3B-ATG3 thioester intermediate formed before lipidation, and we biochemically demonstrate that ATG4B can cleave LC3B-ATG3 conjugates. Finally, we determined ATG3 residue Lys-243 as an LC3B modification site. Overall, we provide the first cellular evidence that mammalian LC3/GABARAP post-translationally modifies proteins akin to ubiquitination ("LC3ylation"), with ATG4 proteases acting like deubiquitinating enzymes to counteract this modification ("deLC3ylation").

Identifiants

pubmed: 31315929
pii: S0021-9258(20)30296-9
doi: 10.1074/jbc.AC119.009977
pmc: PMC6709618
doi:

Substances chimiques

Apoptosis Regulatory Proteins 0
Autophagy-Related Proteins 0
GABARAP protein, human 0
MAP1LC3A protein, human 0
Microtubule-Associated Proteins 0
Ubiquitins 0
ATG4B protein, human EC 3.4.22.-
Cysteine Endopeptidases EC 3.4.22.-

Banques de données

PDB
['2Z0E']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12610-12621

Subventions

Organisme : Wellcome Trust
ID : 105604/Z/14/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M02492X/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_G0800785
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U12266B
Pays : United Kingdom

Informations de copyright

© 2019 Agrotis et al.

Références

J Biol Chem. 2000 Oct 20;275(42):32966-73
pubmed: 10837468
J Cell Biol. 2000 Oct 16;151(2):263-76
pubmed: 11038174
EMBO J. 2000 Nov 1;19(21):5720-8
pubmed: 11060023
J Biol Chem. 2001 Jan 19;276(3):1701-6
pubmed: 11096062
Nature. 2000 Nov 23;408(6811):488-92
pubmed: 11100732
J Cell Biol. 2001 Feb 19;152(4):657-68
pubmed: 11266458
J Biol Chem. 2002 Apr 19;277(16):13739-44
pubmed: 11825910
J Biol Chem. 2002 May 24;277(21):18619-25
pubmed: 11897782
J Biol Chem. 2003 Apr 18;278(16):14053-8
pubmed: 12473658
J Biol Chem. 2003 Aug 1;278(31):29278-87
pubmed: 12740394
J Biol Chem. 2003 Dec 19;278(51):51841-50
pubmed: 14530254
J Cell Sci. 2004 Jun 1;117(Pt 13):2805-12
pubmed: 15169837
J Biol Chem. 2004 Aug 27;279(35):36268-76
pubmed: 15187094
Genome Res. 2004 Oct;14(10B):2128-35
pubmed: 15489335
J Biol Chem. 2006 Feb 10;281(6):3017-24
pubmed: 16303767
FEBS J. 2006 Jun;273(11):2553-62
pubmed: 16704426
Autophagy. 2007 Jan-Feb;3(1):48-50
pubmed: 17102583
J Biol Chem. 2007 Mar 16;282(11):8036-43
pubmed: 17227760
EMBO J. 2007 Apr 4;26(7):1749-60
pubmed: 17347651
Autophagy. 2007 Sep-Oct;3(5):452-60
pubmed: 17534139
J Biol Chem. 2007 Aug 17;282(33):24131-45
pubmed: 17580304
Autophagy. 2007 Nov-Dec;3(6):542-5
pubmed: 17611390
Cell. 2007 Jul 13;130(1):165-78
pubmed: 17632063
J Biol Chem. 2007 Dec 28;282(52):37298-302
pubmed: 17986448
Nature. 2007 Dec 20;450(7173):1253-7
pubmed: 18097414
Mol Biol Cell. 2008 May;19(5):2092-100
pubmed: 18321988
Genome Biol. 2008 Apr 03;9(4):R64
pubmed: 18387192
Mol Biol Cell. 2008 Aug;19(8):3290-8
pubmed: 18508918
Mol Biol Cell. 2008 Nov;19(11):4762-75
pubmed: 18768753
J Biol Chem. 2009 Mar 20;284(12):8023-32
pubmed: 19150980
FEBS Lett. 2009 Apr 2;583(7):1078-83
pubmed: 19285500
EMBO J. 2009 May 6;28(9):1341-50
pubmed: 19322194
Nat Rev Mol Cell Biol. 2009 May;10(5):319-31
pubmed: 19352404
Nat Rev Mol Cell Biol. 2009 Aug;10(8):550-63
pubmed: 19626045
Nature. 2010 Jul 1;466(7302):68-76
pubmed: 20562859
J Clin Invest. 2010 Jul;120(7):2331-44
pubmed: 20577052
Cell. 2010 Aug 20;142(4):590-600
pubmed: 20723759
J Biol Chem. 2011 Mar 4;286(9):7327-38
pubmed: 21177865
J Biol Chem. 2011 Mar 25;286(12):10238-47
pubmed: 21247896
Dev Cell. 2011 Apr 19;20(4):444-54
pubmed: 21497758
Mol Cell. 2011 Oct 21;44(2):325-40
pubmed: 21906983
EMBO J. 2011 Nov 08;30(23):4701-11
pubmed: 22068051
Autophagy. 2012 Feb 1;8(2):177-86
pubmed: 22240591
Oncogene. 2012 Oct 4;31(40):4397-408
pubmed: 22249245
Autophagy. 2012 May 1;8(5):780-93
pubmed: 22622160
Autophagy. 2012 Jun;8(6):883-92
pubmed: 22652539
PLoS One. 2013 Sep 10;8(9):e74222
pubmed: 24040206
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Cell Rep. 2013 Nov 14;5(3):826-38
pubmed: 24210823
Nat Methods. 2014 May;11(5):585-92
pubmed: 24658140
Nat Struct Mol Biol. 2014 Apr;21(4):336-45
pubmed: 24699082
J Biol Chem. 2015 Mar 27;290(13):8146-53
pubmed: 25645919
Nat Cell Biol. 2015 Mar;17(3):300-10
pubmed: 25686249
Bioinformatics. 2015 Sep 15;31(18):3078-80
pubmed: 25979474
J Biol Chem. 2015 Oct 30;290(44):26549-61
pubmed: 26378241
J Cell Sci. 2016 Mar 1;129(5):875-80
pubmed: 26906419
Cell Res. 2016 Apr;26(4):423-40
pubmed: 27002219
Oncotarget. 2016 Jul 5;7(27):41203-41216
pubmed: 27256984
Cancer Cell. 2016 Aug 8;30(2):214-228
pubmed: 27478040
J Cell Biol. 2016 Dec 19;215(6):857-874
pubmed: 27864321
Annu Rev Biochem. 2017 Jun 20;86:193-224
pubmed: 28460188
EMBO J. 2017 Jul 3;36(13):1811-1836
pubmed: 28596378
Nat Commun. 2017 Aug 18;8(1):294
pubmed: 28821708
Nat Commun. 2017 Aug 18;8(1):295
pubmed: 28821724
Nat Commun. 2018 Jan 8;9(1):95
pubmed: 29311554
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Autophagy. 2019 Jun;15(6):976-997
pubmed: 30661429
EMBO J. 1998 Jul 1;17(13):3597-607
pubmed: 9649430
Nature. 1998 Sep 24;395(6700):395-8
pubmed: 9759731
J Biol Chem. 1998 Dec 18;273(51):33889-92
pubmed: 9852036

Auteurs

Alexander Agrotis (A)

MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.

Lucas von Chamier (L)

MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.

Harriet Oliver (H)

MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.

Koshiro Kiso (K)

MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.

Tanya Singh (T)

MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.

Robin Ketteler (R)

MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom r.ketteler@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH